AstraZeneca’s FARXIGA® (dapagliflozin) has received approval from the US Food and Drug Administration (FDA) for improving glycemic control in pediatric patients with type-2 diabetes (T2D) aged 10 years and older.…
The Frankfurt (Oder) Clinic warmly invites you to attend the next themed afternoon as part of the AOK Pfiffs training program. This free event, featuring nutritionist Anja Dehl and pharmacist…
AcariaHealth, a national specialty pharmacy dedicated to improving care and outcomes for patients with complex medical conditions and a wholly owned subsidiary of Centene Corporation (NYSE: CNC), has announced the…
Dr. Michael Schönhofen, head of Fresenius Kabi’s Biopharma business, will leave the company on June 30, 2024, after over 30 successful years. His successor, Dr. Sang-Jin Pak, will join the…
In the dynamic realm of healthcare, the quest for effective interventions persists. Whether it’s pioneering medications, advanced medical tools, or novel treatment approaches, the path from discovery to application is…
MultiPlan Corporation (NYSE: MPLN), a prominent provider of data analytics and technology-driven cost management solutions in the U.S. healthcare sector, has announced the release of its 2023 Environmental, Social, and…
As pharmacies navigate through a myriad of challenges such as workforce shortages, financial management, and increasing responsibilities, they are transforming into vital community healthcare hubs, showcasing their resilience and importance.…
Siemens Healthineers has unveiled the launch of four novel blood biomarkers, enriching its fully automated inflammation testing panel with a total of seven immunoassays. These assays, boasting turnaround times ranging…
CVS Pharmacy, the retail division of CVS Health®, has introduced Well Market™, a new store brand featuring a variety of snacks, beverages, and groceries. “Our goal at CVS Health is…
A global healthcare company is set to host its inaugural ThinkLive Cell and Gene Therapy (CGT) Summit, bringing together leaders from the healthcare and biopharmaceutical industries. This two-day virtual event,…
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company specializing in urothelial and specialty cancer treatments, presents findings from a sub-analysis of JELMYTO (mitomycin) for pyelocalyceal solution at the American Urological…
Epredia, a top player in precise cancer diagnostics and a subsidiary of PHC Holdings Corporation (TSE: 6523), has partnered with NovaScan, Inc., a pioneer in cancer detection technology. Together, they’ve…
